A Nationwide questionnaire survey on the prevalence of ankylosing spondylitis and non-radiographic axial spondyloarthritis in Japan. 2021/11
25.
症例報告
ネフローゼ症候群を呈したV型のループス腎炎にポドサイト障害を認めた一例. 2021/12
26.
原著
Increased Circulating Cell-Free DNA in Eosinophilic Granulomatosis With Polyangiitis: Implications for Eosinophil Extracellular Traps and Immunothrombosis. 2022/01
Abatacept treatment suppresses T cell activation in anti-cyclic citrullinated peptide antibody(ACPA) positive RA patients but not in ACPA negative ra patients. (ポスター,一般) 2013/06/15
16.
Changes in cytokine profiles in rheumatoid arthritis patients during abatacept treatment. (ポスター,一般) 2013/06/15
17.
Effect of abatacept on bone homeostasis and osteopontin in rheumatoid arthritis. (ポスター,一般) 2013/06/15
18.
中枢性尿崩症を合併した限局型GPAの一例. (口頭発表,一般) 2013/06/29
19.
喘息治療のあり方と薬剤師の役割. (口頭発表,一般) 2013/07/20
20.
関節リウマチ治療Up to Date. (口頭発表,一般) 2013/08/10
21.
関節リウマチ治療up to date ~生物学的製剤から低分子化合物へ~. (口頭発表,特別・招待講演等) 2013/08/29
The perturbation of CD8-positive T-cell repertoire in peripheral blood is characteristic for IgG4-related disease. (ポスター) 2013/10/10
27.
中枢性尿崩症を合併した限局型GPAの1例. (口頭発表,一般) 2013/10/12
28.
Higher titer of anti-citrullinated protein antibodies in biologic-naïve rheumatoid arthritis patients are candidate biomarkers to predict sensitivity leadiong to clinicalremission with abatacept; data from the abroad study. (ポスター,一般) 2013/10/27
29.
Treatment responses and their predictors of abatacept in biologic naïve patients with rheumatoid arthritis; data form abroad study. (ポスター,一般) 2013/10/28
30.
Soluble interleukin-2 receptor levels and the CD4/CD8 ratio as predictors of the efficacy of abatacept in biologics-naïve rheumatoid arthritis patients. (ポスター,一般) 2013/10/29
Circulating cell free DNA released from eosinophils is a practical biomarker in patients with eosinophilic granulomatosis with polyangiitis. (ポスター,一般) 2019/11/11
75.
Evaluation of changes in oral health-related quality of life over time in patients with Sjögren’syndrome. (ポスター,一般) 2019/11/11
76.
Relationship between YKL-40, VEGF, and IL-5 in borderline mPAP and pulmonary hypertension in systemic sclerosis. (ポスター,一般) 2019/11/11